Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus

被引:38
|
作者
Stringer, Danielle M. [1 ]
Sellers, Elizabeth A. C. [2 ]
Burr, Laura L. [1 ]
Taylor, Carla G. [1 ]
机构
[1] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB R3T 2N2, Canada
[2] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada
关键词
adipokines; CVD; First Nation; obesity; T2DM; C-REACTIVE PROTEIN; SOLUBLE LEPTIN RECEPTOR; INSULIN-RESISTANCE; INFLAMMATORY MARKERS; CHILDREN; ADIPONECTIN; ATHEROSCLEROSIS; WOMEN; ASSOCIATION; MORTALITY;
D O I
10.1111/j.1399-5448.2008.00473.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stringer DM, Sellers EAC, Burr LL, Taylor CG. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.Pediatric Diabetes 2009: 10: 269-277. To evaluate cardiovascular disease risk in First Nation youth with and without type 2 diabetes mellitus (T2DM) or obesity by comparing pro- and anti-inflammatory adipokines, markers of oxidative stress and the plasma phospholipid fatty acid profile. Self-declared First Nation youth (12-15 yr) with T2DM (n = 24) as well as age-, gender-, and body mass index-matched controls (obese group; n = 19) and unmatched controls (control group; n = 34) were recruited from a pediatric diabetes clinic. Plasma tumor necrosis factor-alpha, ultrasensitive C-reactive protein, resistin, and total antioxidant status were not different among the three groups. Plasma total leptin, soluble leptin receptor, and free leptin were significantly higher in the T2DM group than the control group (p < 0.001, p = 0.019, p < 0.001, respectively) but did not differ from the obese group. Similarly, oxidized low-density lipoprotein was higher in the T2DM group compared with controls (p = 0.002) but not in the obese group. However, interleukin-6 was significantly higher (p < 0.001) in the T2DM group compared with both the control and the obese groups, suggesting that T2DM, but not an increase in adiposity, was responsible for this elevation. Adiponectin was significantly lower in the T2DM group compared with the control group only (p = 0.035). Changes in plasma adipokines and oxidative stress can already be detected in youth with T2DM; however, many of the changes are mirrored in obese youth, suggesting that both these populations are at an increased risk for future cardiovascular complications.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 50 条
  • [11] Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
    Malik, Vasanti S.
    Popkin, Barry M.
    Bray, George A.
    Despres, Jean-Pierre
    Hu, Frank B.
    CIRCULATION, 2010, 121 (11) : 1356 - 1364
  • [12] Obesity and Type 2 Diabetes in Our Youth: A Recipe for Cardiovascular Disease
    Wooton, Angela Kaye
    Melchior, Lynne M.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2017, 13 (03): : 222 - 227
  • [13] Plasma homocysteine, Lp(a), and oxidative stress markers in peripheral macroangiopathy in patients with type 2 diabetes mellitus
    Real, Jose T.
    Folgado, Jose
    Molina Mendez, Mercedes
    Martinez-Hervas, Sergio
    Peiro, Marta
    Ascaso, Juan F.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (04): : 188 - 194
  • [14] Oxidative stress markers in plasma and urine of prepubertal patients with type 1 diabetes mellitus
    Gleisner, A.
    Martinez, L.
    Pino, R.
    Rojas, I. G.
    Martinez, A.
    Asenjo, S.
    Rudolph, M. I.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (08): : 995 - 1000
  • [15] Increased diabetes and cardiovascular disease risk markers in first episode psychosis subjects
    Graham, K
    Cho, H
    Brownley, K
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 135 - 135
  • [16] Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus
    El-Lebedy, Dalia H.
    Ibrahim, Alshaymaa A.
    Ashmawy, Ingy O.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (05) : 643 - 648
  • [17] Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus
    Sellers, Elizabeth A. C.
    Yung, Grant
    Dean, Heather J.
    PEDIATRIC DIABETES, 2007, 8 (06) : 384 - 390
  • [18] No Increased Risk of Cardiovascular Events with Dapagliflozin in Elderly Patients with Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Johansson, Peter A.
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A4 - A4
  • [19] No increased risk of cardiovascular events with dapagliflozin in elderly patients with type 2 diabetes mellitus, cardiovascular disease and hypertension
    Gause-Nilsson, I.
    Sonesson, C.
    Johansson, P. A.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S362 - S363
  • [20] Steatotic Liver Disease in Pediatric Obesity and Increased Risk for Youth-Onset Type 2 Diabetes
    Putri, Resthie R.
    Casswall, Thomas
    Danielsson, Pernilla
    Marcus, Claude
    Hagman, Emilia
    DIABETES CARE, 2024, 47 (12)